Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: Brain Imaging Behav. 2019 Dec;13(6):1674–1688. doi: 10.1007/s11682-019-00038-2

Table 1.

Sample Demographic Characteristics1

Breast Cancer
(n=13 Female)
Healthy Control
(n=13 Female)
Mean (SD) or N(%) Mean (SD) or N(%)
Age at baseline (years) 47.85 (6.4) 48.54 (8.0)
Education (years) 17.23 (2.35) 16.08 (1.71)
Handedness
 Right 13 (100) 13 (100)
 Left 0 (0) 0 (0)
Time between scans (days) 152.69 (22.9) 163.58 (17.98)
Race
 White 4 (30.8) 11 (84.6)
 Black or African-American 2 (15.4) 2 (16.7)
 Asian 5 (38.5) 0 (0)
 Hispanic or Latino 2 (15.4) 0 (0)
 Native Hawaiian or Other Pacific Islander 0 (0) 0 (0)
 American Indian or Alaska Native 0 (0) 0 (0)
Cancer stage
 I 3 (23.1)
 II 6 (46.2)
 III 2 (15.4)
 IV 0 (0)
 No Stage recorded 2 (15.4)
Chemotherapy
 Adriamycin, Cytoxan, and Taxol 9 (69.2)
 Cyclophosphamide, methotrexate, and fluorouracil 4 (30.8)
1

Groups did not significantly differ across demographic characteristics of age (t(24) = 0.243, p = 0.81); education (t(24) = −1.432, p = 0.165); time between scans (t(24) = 0.681, p = 0.502)